METASTATIC UROTHELIAL CANCER
Clinical trials for METASTATIC UROTHELIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC UROTHELIAL CANCER trials appear
Sign up with your email to follow new studies for METASTATIC UROTHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy duo shows promise in Tough-to-Treat bladder cancer
Disease control OngoingThis study tests whether adding the immunotherapy drugs durvalumab and tremelimumab to standard chemotherapy helps people with advanced bladder cancer live longer. About 1,200 participants who have not had prior chemotherapy will receive either chemo alone or chemo plus the immun…
Matched conditions: METASTATIC UROTHELIAL CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 07:58 UTC
-
New hope for advanced bladder cancer: targeted drug combo under trial
Disease control OngoingThis study tests a new drug called BT8009, alone or with another drug (pembrolizumab), in people with advanced bladder cancer that has spread. About 956 participants will be split into two groups: those who haven't had treatment yet and those who have tried other therapies. The g…
Matched conditions: METASTATIC UROTHELIAL CANCER
Phase: PHASE2, PHASE3 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated May 19, 2026 12:00 UTC